An experimental drug has been shown to exceed the efficacy of standard mesothelioma treatments like cisplatin and paclitaxel in studies on laboratory mice. Dubbed HUHS1015, when introduced into lab mice, researchers noted the stoppage of growth in Stage IV mesothelioma tumors.
Stage IV mesothelioma is the final stage of the disease, wherein the metastasized cancer spreads throughout the body. Tumors can be found almost anywhere in the body and are not removable via surgery.
Having a drug that reliably stops the growth of these pervasive tumors could give hope to patients living with the most severe stage of mesothelioma. However, until HUHS1015 passes clinical trials for testing in humans, standard chemotherapy drugs like those mentioned above continue to be a doctor’s first choice for treatment.
The reason mesothelioma is so aggressive is because it resists many treatments normally used to combat cancer. With another experimental procedure showing excellent results, better cancer treatment options for this rare cancer might be right around the corner.
If I Develop Mesothelioma from Asbestos Exposure, Who Is Responsible?
Asbestos exposure normally occurs occupationally, environmentally or due to a secondhand exposure, like breathing in fibers off someone else’s clothes. Throughout the industrial boom in the years following World War II, asbestos was a staple material in the construction field. Because of this, industrial workers from that era may have been exposed to toxic levels of the mineral. Living in a house or working in a building constructed in that era can also lead to exposure.
If you have developed mesothelioma, an experienced attorney can help you pinpoint where you were exposed to asbestos and who should be responsible for your claim. Call the New Orleans mesothelioma lawyers at Harrell & Nowak to schedule a no-obligation consultation with our staff.
Harrell & Nowak, L.L.C. – Louisiana Mesothelioma Attorneys
Did You Know? The earliest mention of a possible tumor of the lungs (pleura) was made in 1767 by Joseph Lieutaud.